Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07442058 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Accelerated and Extended-iTBS Targeting Inhibitory Control in Veterans With ADHD

Study acronym: ACHIEVE
StatusNot Yet Recruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗
Trial flagged as At Risk
Primary completion moved at least 2 months later Oct 1, 2027 → Dec 1, 2027
See other at-risk trials from VA Office of Research and Development

Record History

  1. Start date: Oct 1, 2026 to Dec 1, 2026 Primary completion pushed from Oct 1, 2027 to Dec 1, 2027 · Eligibility criteria expanded, about 30 words · Secondary endpoints: details revised at 6 of 8 entries · 1 more Show 4 more changesShow less
    • Primary completion pushed from Oct 1, 2027 to Dec 1, 2027
    • Eligibility criteria expanded, about 30 words
    • Secondary endpoints: details revised at 6 of 8 entries
    • Study description revised
  2. Start date: Jul 1, 2026 to Oct 1, 2026 Site contact updatedv2 Show 1 more changeShow less
    • Site contact updated
  3. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Impaired inhibitory response manifests clinically as increased impulsivity, which leads to poorer affective, cognitive, social, and occupational functioning. Neuropsychiatric disorders prevalent among Veterans, such as Attention Deficit/Hyperactivity Disorder (ADHD), are associated with poor inhibitory control. The mainstay of clinical treatment for ADHD is psychostimulants, yet these medications have significant risks, including dependence and numerous side effects. Thus, novel and non-pharmacological therapeutic strategies are needed. Intermittent Theta Burst Stimulation, a newer form of transcranial magnetic stimulation, has emerged as a promising tool for modulating inhibitory neuronal circuits. This research proposal will investigate the feasibility and acceptability of iTBS on inhibitory control and impulsivity through a randomized controlled trial to inform clinical observations. The long-term goal is to improve impulsivity, social and occupational functioning, and enhance the quality of life for Veterans.
Trial Details
NCT Number NCT07442058
Lead Sponsor VA Office of Research and Development
Conditions Attention Deficit Disorder With Hyperactivity
Enrollment 35 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov